Cargando…

Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation

Combination use of digoxin and other medications might lead to worse outcomes in patients with atrial fibrillation (AF). We sought to investigate whether digoxin-amiodarone combination would lead to worse outcome than digoxin alone in patients with AF. Adult patients with AF and received digoxin tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiang, Jiun-Yang, Chen, Pau-Chung, Yang, Yao-Hsu, Chang, Chin-Hao, Chu, Fang-Ying, Chen, Jien-Jiun, Wu, Cho-Kai, Hwang, Juey-Jen, Chiang, Fu-Tien, Lin, Lian-Yu, Lin, Jiunn-Lee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058044/ https://www.ncbi.nlm.nih.gov/pubmed/32139765 http://dx.doi.org/10.1038/s41598-020-61065-4

Ejemplares similares

Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study
por: Lai, Kuan-Cheng, et al.
Publicado: (2018)

Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis
por: Lin, Ting-Tse, et al.
Publicado: (2015)

Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial
por: Shojaee, Majid, et al.
Publicado: (2017)

Sodium‐Glucose Cotransporter‐2 Inhibitor Prevents Stroke in Patients With Diabetes and Atrial Fibrillation
por: Chang, Sheng‐Nan, et al.
Publicado: (2023)

Correlation Between CHA(2)DS(2)-VASc Score and Left Atrial Size in Patients With Atrial Fibrillation: A More Than 15-Year Prospective Follow-Up Study
por: Tsai, Chin-Feng, et al.
Publicado: (2021)

CHA2DS2VASc score predicts risk of end stage renal disease in patients with atrial fibrillation: Long-term follow-up study
por: Huang, Pang-Shuo, et al.
Publicado: (2023)

Digoxin in Atrial Fibrillation: An Old Topic Revisited
por: Ferrari, Filipe, et al.
Publicado: (2020)

Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
por: Colella, Antonella, et al.
Publicado: (2022)

Fetal Tachyarrhythmia Management from Digoxin to Amiodarone—A Review
por: Gozar, Liliana, et al.
Publicado: (2022)

Copy number variation of gasdermin D gene is associated with atrial fibrillation-related thromboembolic stroke
por: Huang, Pang-Shuo, et al.
Publicado: (2023)

Use of nicorandil is associated with increased risk of incident atrial fibrillation
por: Lee, Chien-Chang, et al.
Publicado: (2022)

Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis
por: Chen, Ying, et al.
Publicado: (2015)

Digoxin Use and Adverse Outcomes in Patients With Atrial Fibrillation
por: Zeng, Wu-Tao, et al.
Publicado: (2016)

Benefits of prescribing low-dose digoxin in atrial fibrillation
por: Rosca, Ciprian Ilie, et al.
Publicado: (2021)

Digoxin Impact on Heart Failure Patients with Atrial Fibrillation
por: Gerakaris, Andreas, et al.
Publicado: (2022)

An Integrative Comparative Study Between Digoxin and Amiodarone as an Emergency Treatment for Patients With Atrial Fibrillation With Evidence of Heart Failure: A Systematic Review and Meta-Analysis
por: Zaki, Hany A, et al.
Publicado: (2022)

Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillation
por: Tsai, Chia-Ti, et al.
Publicado: (2016)

Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation
por: Zhang, Nixiao, et al.
Publicado: (2018)

Catatonic depression precipitated by amiodarone prescribed for atrial fibrillation
por: Rajagopal, Sundararajan
Publicado: (2015)

Explainable Machine Learning Techniques To Predict Amiodarone-Induced Thyroid Dysfunction Risk: Multicenter, Retrospective Study With External Validation
por: Lu, Ya-Ting, et al.
Publicado: (2023)

Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure
por: Bavendiek, Udo, et al.
Publicado: (2017)

Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study
por: Pastori, Daniele, et al.
Publicado: (2018)

Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillation
por: Kytö, Ville, et al.
Publicado: (2022)

Pharmacokinetic Drug‐Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects
por: Trivedi, Ashit, et al.
Publicado: (2021)

Detrended Fluctuation Analysis of Heart Rate Dynamics Is an Important Prognostic Factor in Patients with End-Stage Renal Disease Receiving Peritoneal Dialysis
por: Chiang, Jiun-Yang, et al.
Publicado: (2016)

Detecting Digoxin Toxicity by Artificial Intelligence-Assisted Electrocardiography
por: Chang, Da-Wei, et al.
Publicado: (2021)

Effect of Digoxin Therapy on Mortality in Patients With Atrial Fibrillation: An Updated Meta-Analysis
por: Wang, Xiaoxu, et al.
Publicado: (2021)

Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
por: Alizadeh, Abolfath, et al.
Publicado: (2022)

Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network
por: Lin, Yubi, et al.
Publicado: (2017)

ROCKET AF adds more concerns about Digoxin safety in patients with atrial fibrillation
por: ElMaghawry, Mohamed
Publicado: (2015)

Safety of digoxin in nonagenarian patients with atrial fibrillation: lessons from the Spanish Multicenter Registry
por: Domínguez-Erquicia, Pablo, et al.
Publicado: (2021)

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
por: Zhang, Mengran, et al.
Publicado: (2021)

Amiodarone vs Dronedarone for Atrial Fibrillation: A Retrospective Cohort Study
por: Brophy, James M., et al.
Publicado: (2022)

Amiodarone in the treatment of atrial fibrillation of patients with rheumatic heart disease after valve replacement
por: Chen, Kebiao, et al.
Publicado: (2019)

Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Dialysis Patients: A Nationwide Data Survey and Propensity Analysis
por: Wu, Cho-Kai, et al.
Publicado: (2015)

Alterations of sympathetic dynamics after atrial fibrillation ablation by analysis sympathetic nerve activity provide prognostic value for recurrence and mechanistic insights into ablation
por: Chen, Jien-Jiun, et al.
Publicado: (2022)

Clinical Characteristics of Atrial Flutter and Its Response to Pharmacological Cardioversion with Amiodarone in Comparison to Atrial Fibrillation
por: Wybraniec, Maciej T., et al.
Publicado: (2023)

Anti-Hyperglycemic Agents and New-Onset Acute Myocardial Infarction in Diabetic Patients with End-Stage Renal Disease Undergoing Dialysis
por: Lin, Ting-Tse, et al.
Publicado: (2016)

Cystatin C may be better than creatinine for digoxin dosing in older adults with atrial fibrillation
por: Šálek, Tomáš, et al.
Publicado: (2020)

Acutely Onset Amiodarone-Induced Angioedema in a Patient with New Atrial Fibrillation
por: Vakili, Hossein, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i6l32g2pvur5de8hhqekjq068c